Helping Clinicians Safely Deliver Medications at the Bedside
A retrospective study estimated there are 1.2 million hospitalizations with preventable adverse drug events (ADE) related to injectable medications. Incremental cost of all preventable ADEs is estimated to be $3.8 billion annually.1
In 2018, the Centers for Disease Control and Prevention observed 19,188 central line-associated bloodstream infections (CLABSIs) reported in U.S. hospitals.2
Focused on Patient Safety
We’re working to enable clinicians to provide their best care to patients and safely deliver medications at the bedside. For example, we are helping elevate patient protection from the pharmacy to the bedside through our infusion pump. We are also focused on helping clinicians reduce the potential for touch contamination during setup and change of IV administration sets with single set technology for both pump and gravity medication delivery.
We recently acquired Cheetah Medical, a leading provider of non-invasive fluid management and hemodynamic monitoring technologies, which will accelerate our presence in the patient monitoring space. The Starling Fluid Management Monitoring System advances efforts to shift treatment away from a one-size-fits-all approach towards individualized, patient-specific clinical decisions that will help deliver the right therapy to the right patient, every time. This platform will join other Baxter devices and products—IV infusion pumps, IV fluids and medications—as part of an integrated system designed to aid and inform therapeutic decisions.
Explore Our Products for Infusion Systems
We offer clinicians an infusion pump system and comprehensive portfolio of sets and vascular access devices to administer IV fluids and drugs for patients at the bedside.